A Phase I trial of prolonged administration of lovastatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck or of the cervix.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  European Journal of Cancer

• Publication date

  2005-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.EJCA.2004.12.013PMID 15737556
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The risk of cancer in users of statins.

  2004cited by this paper
• Phase II Study of High-Dose Lovastatin in Patients with Advanced Gastric Adenocarcinoma

  2004cited by this paper
• HMG CoA reductase inhibitors and the risk of colorectal cancer.

  2004cited by this paper
• Erlotinib: a new therapeutic approach for non-small cell lung cancer

  2003cited by this paper
• The statins as anticancer agents.

  2003cited by this paper
• Statins and myotoxicity

  2003cited by this paper
• Microarray and biochemical analysis of lovastatin-induced apoptosis of squamous cell carcinomas.

  2002cited by this paper
• HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis

  2002cited by this paper
• Differential sensitivity of various pediatric cancers and squamous cell carcinomas to lovastatin-induced apoptosis: therapeutic implications.

  2001cited by this paper
• Determination of Lovastatin in Human Plasma Using Reverse-Phase High-Performance Liquid Chromatography With UV Detection

  2000cited by this paper
• Lovastatin Induces a Pronounced Differentiation Response in Acute Myeloid Leukemias

  2000cited by this paper
• 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and the risk of cancer: a nested case-control study.

  2000cited by this paper
• Coenzyme Q10 in health and disease

  1999cited by this paper
• Lovastatin augments apoptosis induced by chemotherapeutic agents in colon cancer cells.

  1999cited by this paper
• Increased sensitivity of acute myeloid leukemias to lovastatin-induced apoptosis: A potential therapeutic approach.

  1999cited by this paper
• A phase I-II trial of lovastatin for anaplastic astrocytoma and glioblastoma multiforme.

  1998cited by this paper
• Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials.

  1997cited by this paper
• HMG–CoA reductase mediates the biological effects of retinoic acid on human neuroblastoma cells: Lovastatin specifically targets P–glycoprotein–expressing cells

  1996cited by this paper
• Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer.

  1996cited by this paper
• The hypobetalipoproteinemias.

  1995cited by this paper
• Pharmacology of competitive inhibitors of HMG-CoA reductase.

  1995cited by this paper
• Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

  1994cited by this paper
• Cancer statistics, 1994

  1994cited by this paper
• HMG CoA reductase inhibitors

  1992cited by this paper
• Synchronization of tumor and normal cells from G1 to multiple cell cycles by lovastatin.

  1991cited by this paper
• Regulation of the mevalonate pathway

  1990cited by this paper
• Hepatocellular Carcinoma (hcc) Causes Death in Patients with Cirrhosis and Is One of the Most Prevalent Malignant Tumours Effect of Pravastatin on Survival in Patients with Advanced Hepatocellular Carcinoma. a Randomized Controlled Trial

  year unknowncited by this paper

• Evaluating the oncologic impact of statin use in gynecologic cancers: a critical review of pre-clinical and clinical evidence.

  2026cites this paper
• Targeting SREBP2 in cancer progression: Molecular mechanisms, oncogenic crosstalk, and therapeutic interventions.

  2025cites this paper
• Investigation of simvastatin and fluvastatin permeation across cell membrane models using molecular dynamics simulations.

  2025cites this paper
• Downregulation of acetyl-CoA carboxylase induces ferroptosis and inhibits tumor growth in oral squamous cell carcinoma

  2025cites this paper
• The Expendables: Overlooked Medications with Anti-Cancer Properties

  2025cites this paper
• Downregulation of acetyl-CoA carboxylase suppresses the malignant progression of oral cancer

  2024cites this paper
• Statin therapy enhances survival in unresectable stage III lung squamous cell carcinoma with concurrent chemoradiotherapy.

  2024cites this paper
• Lipid Metabolic Reprogramming in Embryonal Neoplasms with MYCN Amplification

  2023cites this paper
• Drastic Synergy of Lovastatin and Antrodia camphorata Extract Combination against PC3 Androgen-Refractory Prostate Cancer Cells, Accompanied by AXL and Stemness Molecules Inhibition

  2023cites this paper
• Drug repurposing as a potential source of innovative therapies in cervical cancer

  2022cites this paper
• Computational pharmacogenomic screen identi es drugs that phenocopy dipyridamole and potentiate anti-breast cancer activity of statins

  2022cites this paper
• Computational pharmacogenomic screen identifies drugs that potentiate the anti-breast cancer activity of statins

  2022cites this paper
• A Phase III Randomized Clinical Trial Study of Chemoradiation using Lovastatin/Cisplatin in Patients with Head and Neck Squamous Cell Carcinoma

  2021cites this paper
• The role of statins in lung cancer

  2021cites this paper
• Statins as adjuvants in the treatment of ovarian cancer: controversy and misunderstanding.

  2021cites this paper
• Statins as Anticancer Agents in the Era of Precision Medicine

  2020cites this paper
• Statins as anti-cancer agents in the era of precision medicine

  2020cites this paper
• Recycling the Purpose of Old Drugs to Treat Ovarian Cancer

  2020cites this paper
• Computational pharmacogenomics screen identifies synergistic statin-compound combinations as anti-breast cancer therapies

  2020cites this paper
• Cyclic AMP‐hydrolyzing phosphodiesterase inhibitors potentiate statin‐induced cancer cell death

  2020cites this paper
• Targeting the Mevalonate Pathway Enhances the Efficacy of Epidermal Growth Factor Receptor – Tyrosine Kinase Inhibitors in Head and Neck Squamous Cell Carcinoma

  2020cites this paper
• Chemopreventive Agents in Oral Premalignancy: A Medical Management Review

  2020cites this paper
• Statin-induced GGPP depletion blocks macropinocytosis and starves cells with oncogenic defects

  2020cites this paper
• DOCTORAL THESIS TARGETING OF THE PROTUMOR MICROENVIRONMENTAL PROCESSES BY LIPOSOMAL SIMVASTATIN-BASED TREATMENTS IN COLORECTAL CANCER

  2019cites this paper
• An actionable sterol-regulated feedback loop modulates statin sensitivity in prostate cancer

  2019cites this paper
• Targeting Cellular Metabolism Modulates Head and Neck Oncogenesis

  2019cites this paper
• Statin‐dependent modulation of mitochondrial metabolism in cancer cells is independent of cholesterol content

  2019cites this paper
• Regulatory mechanisms of fluvastatin and lovastatin for the p21 induction in human cervical cancer HeLa cells

  2019cites this paper
• PPARγ Agonists in Combination Cancer Therapies.

  2019cites this paper
• The Potential of Isoprenoids in Adjuvant Cancer Therapy to Reduce Adverse Effects of Statins

  2019cites this paper
• Advances in Analytical and Pharmaceutical Chemistry Study of the Effect of Statins on a Variety of Null, Wild Type, and Mutant p53 Cancer Cell Lines

  2019cites this paper
• Effect of statin use on oncologic outcomes in head and neck squamous cell carcinoma

  2018cites this paper
• Does metformin usage improve survival in head and neck squamous cell carcinoma? A population-based study

  2018cites this paper
• The poor design of clinical trials of statins in oncology may explain their failure - Lessons for drug repurposing.

  2018cites this paper
• Protective effects of metformin, statins and anti-inflammatory drugs on head and neck cancer: A systematic review.

  2018cites this paper
• Statins: a new approach to combat temozolomide chemoresistance in glioblastoma

  2018cites this paper
• Dietary geranylgeraniol can limit the activity of pitavastatin as a potential treatment for drug-resistant ovarian cancer

  2017cites this paper
• Statins and the Brain: More than Lipid Lowering Agents?

  2017cites this paper
• Antiglioma effects of N6‐isopentenyladenosine, an endogenous isoprenoid end product, through the downregulation of epidermal growth factor receptor

  2017cites this paper
• Statins and risk of cancer: A meta-analysis of randomized, double-blind, placebo-controlled trials.

  2017cites this paper
• How to Target Activated Ras Proteins: Direct Inhibition vs. Induced Mislocalization.

  2016cites this paper
• Apoptotic effect of atorvastatin in glioblastoma spheroids tumor cultured in fibrin gel.

  2016cites this paper
• A phase I study of high-dose rosuvastatin with standard dose erlotinib in patients with advanced solid malignancies

  2016cites this paper
• Repositioning of drugs for intervention in tumor progression and metastasis: Old drugs for new targets.

  2016cites this paper
• Serendipity in Cancer Drug Discovery: Rational or Coincidence?

  2016cites this paper
• Statins are potential anticancerous agents (review).

  2015cites this paper
• Safety and efficacy of the addition of simvastatin to cetuximab in previously treated KRAS mutant metastatic colorectal cancer patients

  2015cites this paper
• In vitro Anti-Tumor Effects of Statins on Head and Neck Squamous Cell Carcinoma: A Systematic Review

  2015influential citation
• Safety and efficacy of the addition of simvastatin to panitumumab in previously treated KRAS mutant metastatic colorectal cancer patients

  2015cites this paper
• Statins as anti-cancer therapy; Can we translate preclinical and epidemiologic data into clinical benefit?

  2015cites this paper
• Zoledronic acid and atorvastatin inhibit αvβ3-mediated adhesion of breast cancer cells

  2014cites this paper
• Monensin Inhibits Epidermal Growth Factor Receptor Trafficking and Activation: Synergistic Cytotoxicity in Combination with EGFR Inhibitors

  2014cites this paper
• Simvastatin Enhances the Effects of Radiotherapy and Cetuximab on a Cell Line (FaDu) Derived from a Squamous Cell Carcinoma of Head and Neck

  2014cites this paper
• Simvastatin suppresses head and neck squamous cell carcinoma ex vivo and enhances the cytostatic effects of chemotherapeutics

  2014cites this paper
• Small Molecule Therapeutics Monensin Inhibits Epidermal Growth Factor Receptor Traf fi cking and Activation : Synergistic Cytotoxicity in Combination with EGFR Inhibitors

  2014cites this paper
• Lovastatin‐induced apoptosis is mediated by activating transcription factor 3 and enhanced in combination with salubrinal

  2014cites this paper
• Synergistic antiproliferative and anticholesterogenic effects of linalool, 1,8-cineole, and simvastatin on human cell lines.

  2014cites this paper
• New strategies for the treatment of ovarian cancer.

  2014cites this paper
• Anticancer properties of Monascus metabolites

  2014cites this paper
• Rho-GTPases and Statins: A Potential Target and a Potential Therapeutic Tool Against Tumors?

  2014cites this paper
• Statins: perspectives in cancer therapeutics.

  2013cites this paper
• Pharmacokinetics of high-dose simvastatin in refractory and relapsed chronic lymphocytic leukemia patients

  2013cites this paper
• Synergistic killing effect of imatinib and simvastatin on imatinib-resistant chronic myelogenous leukemia cells

  2013cites this paper
• The Mevalonate Pathway: A Potential Therapeutic Target for JAK2-driven Myeloproliferative Neoplasms

  2013cites this paper
• HIGH DOSE SIMVASTATIN AS A POTENTIAL ANTICANCER THERAPY IN LEUKEMIA PATIENTS

  2013cites this paper
• Obesity, Inflammation, and Breast Cancer

  2013cites this paper
• Novel Combination Therapy: Monensin Potentiates Erlotinib-Induced Cytotoxicity.

  2013cites this paper
• Inhibition of lung carcinogenesis by polymethoxyflavones

  2013cites this paper
• Statins and cancer: current and future prospects.

  2012cites this paper
• Cell Cycle Inhibition without Disruption of Neurogenesis Is a Strategy for Treatment of Aberrant Cell Cycle Diseases: An Update

  2012cites this paper
• Pharmacological Actions of Statins: A Critical Appraisal in the Management of Cancer

  2012influential citation
• Anticancer activity of the cholesterol exporter ABCA1 gene.

  2012cites this paper
• Targeting tumor cell metabolism with statins

  2012cites this paper
• Lovastatin Induces Multiple Stress Pathways Including LKB1/AMPK Activation That Regulate Its Cytotoxic Effects in Squamous Cell Carcinoma Cells

  2012cites this paper
• Chapter 12 - The Isoprenoid Biosynthetic Pathway and Statins

  2011cites this paper
• Molecular Rationale and Determinants of Sensitivity for Statin-Induced Apoptosis of Human Tumour Cells

  2011cites this paper
• Statins are logical candidates for overcoming limitations of targeting therapies on malignancy: their potential application to gastrointestinal cancers

  2011influential citation
• Common cardiovascular medications in cancer therapeutics.

  2011cites this paper
• Lovastatin Sensitizes Lung Cancer Cells to Ionizing Radiation: Modulation of Molecular Pathways of Radioresistance and Tumor Suppression

  2011cites this paper
• The combination of pan-ErbB tyrosine kinase inhibitor CI-1033 and lovastatin: A potential novel therapeutic approach in squamous cell carcinoma of the head and neck

  2011influential citation
• Mechanism and Therapeutic Potential of Statin-Mediated Inhibition of Tyrosine Kinase Receptors

  2011cites this paper
• Lovastatin Inhibits VEGFR and AKT Activation: Synergistic Cytotoxicity in Combination with VEGFR Inhibitors

  2010cites this paper
• Statins can modulate effectiveness of antitumor therapeutic modalities

  2010cites this paper
• Lovastatin induces apoptosis of ovarian cancer cells and synergizes with doxorubicin: potential therapeutic relevance

  2010cites this paper
• Diverse Effects of Statins on Angiogenesis: New Therapeutic Avenues

  2010cites this paper
• Therapeutic modulation of k-ras signaling in colorectal cancer.

  2010cites this paper
• Fluvastatin, a lipophilic statin, induces apoptosis in human hepatocellular carcinoma cells through mitochondria-operated pathway.

  2010cites this paper
• Cardiac cachexia: a systematic overview.

  2009influential citation
• Induction of iodide uptake in transformed thyrocytes: a compound screening in cell lines

  2009cites this paper
• Statins induce lethal effects in acute myeloblastic lymphoma cells within 72 hours

  2008cites this paper
• Phase II trial of the histone deacetylase inhibitor vorinostat (Zolinza™, suberoylanilide hydroxamic acid, SAHA) in patients with recurrent and/or metastatic head and neck cancer

  2008cites this paper
• New developments in medulloblastoma treatment: the potential of a cyclopamine–lovastatin combination

  2008cites this paper
• Targeting p53 to mitochondria for cancer therapy

  2008cites this paper
• Novel approaches in anti-angiogenic treatment targeting endothelial F-actin: a new anti-angiogenic strategy?

  2008cites this paper
• [The anticancer properties of statins].

  2008cites this paper
• Statins in prevention and therapy of cancer

  2008cites this paper
• Właściwości przeciwnowotworowe statyn The anticancer properties of statins

  2008cites this paper
• Statins in tumor suppression.

  2008cites this paper
• Statins Inhibit Proliferation and Induce Apoptosis in Barrett's Esophageal Adenocarcinoma Cells

  2008cites this paper
• Shinshu University Institutional Repository SOAR-IR

  2008cites this paper